Categories AlphaGraphs, Earnings, Retail
Earnings preview: Gap’s struggles are likely to continue in Q2
Gap Inc. (NYSE: GPS) is scheduled to report second quarter 2019 earnings results on Thursday, August 22, after regular hours. Analysts have forecast earnings of $0.53 per share on revenue of $4.02 billion.
Gap has been struggling with weakness in its namesake brand mainly due to operational and assortment issues and this weakness has weighed on the top line in general. The company has been restructuring this business in order to revitalize the Gap brand but these efforts might not be sufficient to drive growth in the second quarter.
Gap has also seen comp sales decline in the past two quarters with decreases across all its brands. These declines are likely to continue in the to-be-reported quarter. The company is also likely to face pressures from the ongoing trade war and the resultant tariffs.
Earlier this year, the management decided to split the company into two separate public entities. The focus of the restructuring is the separation of the Old Navy brand, which accounts for nearly half of its sales.
In the first quarter of 2019, Gap missed sales and earnings estimates due to disappointing comps. Net sales dropped 2% to $3.7 billion while adjusted EPS totaled $0.24. Comp sales declined 4% with decreases across all its brands.
Also see: Gap Inc. Q1 2019 Earnings Conference Call Transcript
For fiscal 2019, Gap expects unadjusted earnings in the range of $2.04-2.14 per share. The forecast for adjusted earnings is $2.05-2.15 per share. Full-year comparable store sales are expected to be down low single digits.
Shares of Gap have dropped 36% year-to-date and 26% in the past three months. The majority of analysts have rated it as Hold and the average price target is $20.54.
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on